On January 22, 2019 Seattle Genetics, Inc. (Nasdaq: SGEN) reported that it will report its fourth quarter and full year 2018 financial results on Thursday, February 7, 2019 after the close of financial markets. Following the announcement, company management will host a conference call and webcast discussion of the results and provide a general corporate update. Access to the event can be obtained as follows (Press release, Seattle Genetics, JAN 22, 2019, View Source [SID1234532817]):

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

LIVE access on Thursday, February 7, 2019
1:30 p.m. Pacific Time / 4:30 p.m. Eastern Time

Telephone 877-260-1479 (domestic) or +1 334-323-0522 (international); conference ID 1660553
Webcast available at www.seattlegenetics.com in the Investors section
REPLAY access

Telephone replay will be available beginning at approximately 4:30 p.m. PT on Thursday, February 7, 2019 through 5:00 p.m. PT on Monday, February 11, 2019 by calling 888-203-1112 (domestic) or +1 719-457-0820 (international); conference ID 1660553
Webcast replay will be available on the Seattle Genetics website at www.seattlegenetics.com in the Investors section